16 Recruiting Schizophrenia Phase 3 Clinical Trials
Active phase 3 studies for schizophrenia enrolling across the USA. Verify eligibility and contact site coordinators.
All Schizophrenia studiesPhase 3 Studies for Schizophrenia
Treating Schizophrenia by Correcting Abnormal Brain Development
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
View Study & Checklist ➔Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
📍 Local Institution - 0133 — Bentonville, Arkansas
View Study & Checklist ➔NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
📍 Neurocrine Clinical Site — Bryant, Arkansas
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
📍 Advanced Research Center Inc. — Anaheim, California
View Study & Checklist ➔Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
📍 Alkermes Investigator Site — Dothan, Alabama
View Study & Checklist ➔A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively
📍 Local Institution - 0054 — Dothan, Alabama
View Study & Checklist ➔NBI-1117568-SCZ3030: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
📍 Neurocrine Clinical Site — Culver City, California
View Study & Checklist ➔NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
📍 Neurocrine Clinical Site — Bryant, Arkansas
View Study & Checklist ➔Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
📍 Reviva site — Phoenix, Arizona
View Study & Checklist ➔Safety and Tolerability Trial of Lumateperone in Pediatric Patients With Schizophrenia, Bipolar Disorder or Autism Spectrum Disorder
📍 Southwest Autism Research and Resource Center — Phoenix, Arizona
View Study & Checklist ➔Efficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
📍 ProScience Research Group — Culver City, California
View Study & Checklist ➔Randomized Withdrawal Study in Patients With Schizophrenia
📍 Vanda Investigational Site — Rogers, Arkansas
View Study & Checklist ➔A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia
📍 Pillar Clinical Research LLC - Bentonville Site — Bentonville, Arkansas
View Study & Checklist ➔Efficacy of NBI-1117568 in Preventing Relapse in Adults With Schizophrenia
📍 Neurocrine Clinical Site — Garden Grove, California
View Study & Checklist ➔52-week Open Label Safety-Tolerability Study
📍 Chandler Clinical Trials — Chandler, Arizona
View Study & Checklist ➔Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
📍 Pillar Clinical Research — Bentonville, Arkansas
View Study & Checklist ➔